The regulatory mechanisms underlying myometrial smooth muscle contractility during labor are poorly understood. The authors therefore investigated the transcriptional profile of the changes that occur in the human myometrium at term pregnancy when compared with that at labor. Microarray technology was used to identify differentially expressed genes in human myometrium at labor. Real-time fluorescence reversetranscriptase polymerase chain reaction (RT-PCR) was subsequently performed to verify the microarray data. Semiquantitative RT-PCR, Western blotting, and microscopy methodologies were also used. Certain novel genes were found to be upregulated in human myometrium at labor. Of these, PSCDBP, TLR2, TWIST1, FLJ35382, and RGS12 have not been previously characterized or identified in human myometrium. EDNRB is the other novel labor-associated gene whose reported expression is also upregulated at labor. All 6 genes were expressed on human myometrial smooth muscle cells. These novel upregulated genes are involved in multiple pathways that may be associated with a variety of cellular processes including inflammation, transcriptional regulation, and intracellular signaling.
D uring human labor, the uterus undergoes dramatic changes in its contractile activity, whereby the myometrium is transformed from a state of relative quiescence to one of maximal contractile activity. 1 The regulatory mechanisms underlying uterine smooth muscle contractility during labor are poorly understood. Information relating to these mechanisms is essential to understand the underlying etiology of disorders associated with human parturition such as preterm labor. Preterm labor affects 5% to 10% of all pregnancies and accounts for 70% to 75% of early neonatal morbidity and mortality. 2 Myometrial samples were carefully dissected to minimize decidual inclusion.Women who had received prostaglandins or oxytocin for either induction or augmentation of labor were excluded from the study.The criteria for inclusion in the intrapartum group were regular spontaneous uterine contractions, effacement of the cervix, and cervical dilatation >3 cm prior to cesarean section.Women with malignant conditions and those receiving exogenous hormone therapy (eg, progestagens) were excluded from the study. There was no evidence of clinical chorioamnionitis in any of the subjects recruited for this study.All pregnancies were singleton pregnancies. Immediately on removal, biopsies were rinsed in sterile saline and used directly for primary cell preparation or snap frozen in liquid nitrogen and stored at −80°C until RNA isolation.
Myometrial Cell Isolation and Culture
Myometrial tissue samples were minced (finely and any fibrous tissue removed) and digested in sterile filtered Dulbecco Modified Eagle medium (minus calf serum) containing 1 mg/mL collagenase type IA and 1 mg/mL collagenase type XI and 0.1% bovine serum albumin (BSA; Sigma-Aldrich, Dublin, Ireland) for 45 minutes. The resulting suspension was vortexed, and the nondispersed tissue fragments were separated by filtration of the mixture through sterile gauze layers. Individual cells were then collected by centrifugation at 400g for 10 minutes. Cells were then washed and centrifuged 2 to 3 times in sterile phosphate-buffered saline (PBS). After washing cells were cultured in SGM-2 medium (Cambrex, Biowhittaker, Wokingham, UK) at 37°C and 5% CO 2 . Cells were subcultivated with trypsin/EDTA at a 1:2 or 1:3 split after reaching confluence.
Myometrial smooth muscle cells subpassaged from primary cells in culture were characterized for mRNA expression of calponin and estrogen receptor α and for SMα actin mRNA and protein expression.
RNA Extraction
Total RNA was isolated from human myometrium using TRIzol reagent (Life Technologies, UK). 8 Total RNA was isolated from the myometrial smooth muscle cells (passage 6) using the RNeasy mini RNA isolation kit (Qiagen, Crawley, UK). To eliminate any residual contaminating genomic DNA, all RNA samples were DNase-treated with a DNA removal kit (Ambion, Spitfire Close Huntingdon, UK). The RNA samples were then denatured at 65°C for 10 minutes. RNA concentration was determined by absorbance at A 260 and also using the Ribogreen RNA quantitation kit (Molecular Probes, Eugene, OR) or with the Nanodrop (Nanodrop Technologies,Wilmington, DE).
Microarray Experiments
The concentration and quality of the total RNA were assessed by spectrophotometry (Nanodrop) and a bioanalyzer (Agilent, Santa Clara, CA). Reverse transcription in vitro transcription (RT-IVT) digoxigenin (DIG) labeling was performed on 0.5 μg total RNA in accordance to the Applied Biosystems Chemiluminescent RT-IVT labeling protocol (Applied Biosystems, Foster City, CA). All samples were analyzed separately without pooling of extracted RNA. QC procedures (Nanodrop and Agilent bioanalyzer) were carried out on the cRNA samples to confirm the quality and quantity of the cRNA. The 6 DIG labeled cRNA samples were fragmented and subsequently prepared for hybridization to Applied Biosystems Genome Survey Microarray (version 2): 32 878 probes for 29 098 genes, for 16 hours, 3 chips (NL) and 3 chips (L). Following hybridization the arrays were stained using the Applied Biosystems Chemiluminescence detection kit, with an anti-DIG antibody-alkaline phosphatase conjugate. Interaction of alkaline phosphatase, enhancer, and chemiluminescent substrate produced light with an emission maximum of 458 nm.The arrays were then scanned using the Applied Biosystems 1700 Chemiluminescent Microarray Analyzer (ABI; Geneservice, Cambridge, UK). Spotfire DecisionSite for Functional Genomics (Tibco Software,Palo Alto,CA),Bioconductor (www.bioconductor .org), Panther (ABI), Genomatix Bibliosphere Pathway (Genomatix Software, Munich, Germany) analysis tools were used for data analysis. The signal intensity for each gene across the 6 samples was determined and signal/ noise calculated; standard deviation, coefficient of variance, z scores, and quantiles were also computed. Normalized signal for each of the 3 NL and 3 L samples were averaged, the [log 2 (L(average)/NL(average))] was calculated and the fold change determined. The Spotfire profile ANOVA algorithm was used to determine the P values where values less than .05 were considered significant.
Reverse Transcription
RNA (500 ng, DNase I treated) was reverse transcribed into complementary DNA (cDNA) for use as a template for polymerase chain reaction (PCR). Reverse transcription was performed at 42°C for 60 minutes in a reaction volume of 20 μL containing the following:oligo dT primer (500 ng), Moloney murine leukemia virus (M-MLV) reverse transcription buffer (50 mmol/L Tris-HCl [pH 8.3], 75 mM KCl, 3 mmol/L MgCl 2 , 10 mmol/L dithiothreitol [DTT; Promega, Southampton, UK]), diethylpyrocarbonate-treated water (Sigma-Aldrich), deoxyribonucleotide triphosphates (dNTPs; 0.2 mmol/L; Promega), and 200 U M-MLV reverse transcriptase (Promega). Reverse transcriptase activity was stopped by heating samples at 65°C for 10 minutes. Control RNA samples, in which no reverse transcriptase was added, were included to confirm that no genomic DNA contamination was present.
Real-Time Fluorescence PCR Using ABI Prism 7000 Technology
Real-time PCR was performed on a 1/125 dilution of each of the 7 NL and 6 L myometrial cDNAs in triplicate for each transcript, using the Applied Biosystems ABI Prism 7000 sequence Detection System (ABI).The PCR reactions were performed in a final volume of 25 μL containing 12.5 μL Sybr Green PCR Master Mix (ABI), 5 μL diluted cDNA, and 0.4 μM of each sense and antisense primer. The final volume of 25 μL was achieved using PCR grade water (Sigma-Aldrich). cDNA amplification was performed by an initial step of 50°C for 2 minutes, an initial denaturation step at 95°C for 10 minutes, followed by 40 cycles of denaturation at 95°C for 15 seconds, annealing at 60°C, and elongation at 72°C for 30 seconds each. The sequences of the oligonucleotide primers for each gene are presented in Table 1 . Fluorescence data were acquired at the end of each PCR cycle. Melting curve analysis was performed by an initial denaturation step of 95°C for 15 seconds, cooling to 60°C for 10 seconds, and then to 72°C for 15 seconds. Fluorescence was measured continually during the melting curve cycle. The mean cycle threshold (Ct) of each gene for every patient (performed in triplicate) from their standard curves was normalized to the corresponding mean Ct value of β-Actin (ACTB), Gene Ct values/ACTB Ct values. β-Actin is a housekeeping gene, it is constitutively expressed, and it is used to normalize mRNA levels between different samples. The normalized Ct values of the 7 NL and the 6 L myometrial tissue types (NL vs L) were analyzed using the independent samples t test. Results were expressed as mean normalized Ct units ± the standard error of the mean (SEM). A P value of <.05 was considered to be statistically significant. Relative fold changes were then calculated using the difference in the mean normalized Ct values (x) between the pregnant at-term and the laboring myometrium for each transcript, Relative fold change = 2 x . All statistical analyses were performed using the SPSS statistical package (Statistical Package for the Social Sciences, v 11; SPSS Inc, Chicago, IL).
PCR
One microliter of the 20-μL reverse-transcriptase reaction was then used in the subsequent PCR. PCR was performed in a final volume of 50 μL containing 1.5 mmol/L MgCl 2 , 20 mmol/L Tris-HCl, 50 mmol/L KCl (pH 8.3), 1.25 U Taq DNA polymerase (Bioline, London, UK), 0.2 mM dNTPs, and 0.2 μM of each sense and antisense primer. cDNA amplification was carried out by an initial denaturation step of 5 minutes at 95°C followed by 28 to 
Antisense 5′-AGTTGGTGACGATGCCGTG-3′ (accession number M10277) TLR2 sense 5′-GCCTCTCCAAGGAAGAATCC-3′ 9 Antisense 5′-TCCTGTTGTTGGACAGGTCA-3′ TWIST1 sense 5′-CACTGAAAGGAAAGGCATCA-3′ 10 Antisense 5′-GGCCAGTTTGATCCCAGTAT-3′ EDNRB sense 5′-GCCAAGGACCCATCGAGAT-3′ 11 Antisense 5′-GAAGTGTGGAGTTCCCGATGAT-3′
Abbreviation: RT-PCR, reverse-transcriptase polymerase chain reaction. 40 cycles of denaturation at 94°C for 1 minute, annealing at 55 to 60°C for 1 minute, and elongation at 72°C for 30 seconds to 1 minute, followed by a final extension step at 72°C for 10 minutes. Ten microliters of each PCR product was then separated by gel electrophoresis on 1% to 1.5% agarose gels. Products were separated alongside a 100-bp DNA molecular weight ladder (Promega) for sizing.
Protein Isolation
Human myometrial tissue or human primary uterine smooth muscle cells were homogenized in protein lysis buffer: 50 mM Tris (pH 7.4), 100 mM NaCl, 5 mM MgCl 2 , 0.1% Triton X-100, 10% glycerol with inhibitors (10 μg/mL leupeptin, 10 μg/mL aprotinin, 1 mM PMSF) in ice-cold buffer (Sigma-Aldrich). Cellular debris was removed by centrifugation at 10 000g, 4°C for 15 minutes.The resultant supernatant was used for Western blot analysis. Protein concentrations were determined using the Pierce BCA protein assay reagent kit (Promega) as per the manufacturer's protocol, with BSA as a standard.
Western Blot Analysis
Protein samples (30 μg) were resolved by electrophoresis on 7.5% to 12% SDS polyacrylamide gel electrophoresis gels (Bio-Rad Laboratories, Hercules, CA) and electroblotted. Membranes were blocked with PBS containing 0.05% Tween 20 (Sigma-Aldrich) and 5% low-fat milk powder (Dawn Dairies, Westmeath, Ireland). Blots were either incubated with a 1:500 dilution of primary rabbit antihuman TWIST H- 31 
Immunogold Transmission Electron Microscopy
Fresh myometrial biopsy from an elective cesarean section underwent primary fixation in 2.5% glutaraldehyde/2% paraformaldehyde and was sectioned into smaller segments, with secondary fixation in osmium tetroxide. The samples were dehydrated in alcohol and then placed in epoxypropane and gradually introduced to 100% TAAB resin. The samples in the resin were poured into beam capsule molds and placed in a 60°C oven overnight to polymerize. Ultrathin sections (60-90 nm) were were cut from them on the Leica EM FC6 ultramicrotome (Leica, Bannockburn, IL). The ultrathin sections were then mounted on nickel grids and incubated with goat polyclonal IgG antihuman primary antibody, RGS12 (A-14 sc17740; Santa Cruz) overnight. Grids were washed and then incubated in EM rabbit antigoat IgG (H + L) 10-nm gold particle conjugated secondary antibody (EM-RGHA10; Agar Scientific, Essex, UK) for 1 hour. The negative control was incubated without the primary antibody.They were stained with uranyl acetate and lead citrate. Visualization was performed using a Hitachi transmission electron microscope (Hitachi,Tokyo, Japan).
RESULTS

Tissue Samples for Microarray and mRNA Expression
For the microarray experiment, biopsies of myometrium were obtained at the time of elective NL (n = 3) and intrapartum L (n = 3) cesarean section.The reason for elective cesarean section included previous cesarean section in all cases. The reasons for emergency cesarean section were face presentation (n = 1), previous classical cesarean section (n = 1), and nonreassuring fetal testing (n = 1).The demographic information for the microarray study patients is presented in Table 2 . For real-time RT-PCR confirmation analysis, biopsies of myometrium were obtained at the time of elective (n = 7) and intrapartum (n = 6) cesarean section.The reasons for elective cesarean section included previous cesarean section (n = 6) and placenta previa (n = 1). The reasons for emergency cesarean section were face presentation (n = 4), nonreassuring fetal testing (n = 1), and previous classical cesarean section (n = 1). Patient demographic information for the real time fluorescence RT-PCR analysis is presented in Table 3 .
Microarray Analysis
Microarray analysis of the total RNA from 3 pregnant human nonlaboring myometrial biopsies and 3 laboring myometrial biopsies resulted in the differential expression of 698 genes, P < .05, and 105 genes, P < .01, respectively. In addition to a number of genes, known from previous investigations to be upregulated in human laboring myometrium, including IL-6, 12 phospholipase A2, 13 CCL2, 14 TNFRS11B, 6 EGR1, 6 HLF, 7 TAGLN2, 7 a number of novel genes, which had not been previously reported to be expressed in the myometrium, were found to be upregulated in the laboring tissues according to the microarray data. These included pleckstrin homology, Sec 7 and coiled coil domains, binding protein (PSCDBP), endothelin-β receptor (EDNRB), toll-like receptor 2 (TLR2), TWIST1 and regulator of G-protein signaling-12 (RGS12), and unidentified genes, including FLJ35382. These 6 novel genes were chosen for further analysis.
RT-PCR
RT-PCR analysis using DNA-free treated (Ambion) RNA demonstrated expression of PSCDBP, EDNRB, TLR2, FLJ35382, TWIST1, and RGS12 and β-actin (ACTB) both in nonlaboring and laboring human myometrium (data not shown).The absence of transcripts in reverse transcriptase negative reactions (RT−) confirmed that all products were RNA derived and not generated from contaminating genomic DNA.
Real-Time Fluorescence RT-PCR
Relative quantitative expression analysis was performed by real-time RT-PCR. To minimize any undue experimental error from sources such as pipetting inaccuracies, analysis of each gene was performed in triplicate. All nonlaboring and laboring myometrial biopsies demonstrated expression of PSCDBP, EDNRB, TLR2, FLJ35382, TWIST1, and RGS12 and β-actin (ACTB) mRNA. RT-PCR product specificity was confirmed using melting curve analysis. Amplification curve crossing points were determined for each gene generated within the initial phase of exponential amplification, per 0.5 μg total RNA in the tissues studied.The mean Ct values for each transcript normalized to β-actin (per 0.5 μg total RNA) were then averaged and values determined for both laboring (n = 6) and nonlaboring myometrium (n = 7). The mean β-Actin normalized Ct values for NL and L (±SEM), respectively, for the 6 genes were as follows: Figure 1A ). Individual gene expression levels showed significant difference between laboring and nonlaboring human myometrium (P < .05). Relative fold changes were then calculated using the difference in the Ct values (x) between the laboring and nonlaboring myometrium for each transcript, Relative fold change = 2 x . FLJ35382 showed the greatest relative fold change by real-time RT-PCR at labor (11.3 fold upregulation) when compared with the nonlaboring at-term myometrium. PSCDBP, TLR2, TWIST1, EDNRB, and RGS12 showed 9.89-, 7.59-, 5.74-, 5.67-, and 5.18-fold, respectively, relative increase in mRNA expression at labor. A summary of the fold changes observed using real-time RT-PCR, and the associated P values, is shown in Figure 1B .
Human Myometrial Smooth Muscle Cell RT-PCR
To determine cellular expression, RT-PCR analysis was performed using DNA-free treated RNA from primary human myometrial smooth muscle cells (passage 6). RGS12, PSCDBP, FLJ35382, TWIST1, EDNRB, and TLR2 mRNA expression was demonstrated in the myometrial cells (Figure 2A-F) . 
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Human Myometrial Smooth Muscle Cell Western Blotting
Western blotting was performed on human myometrial smooth muscle cells (passage 6) using antibodies to TWIST1 and RGS12. Protein bands of the expected sizes were observed on the myometrial cell blots, 28 to 30 kDa for TWIST1 and 76 to 80 kDa for RGS12 ( Figure 3A and B ).
Immunofluorescence Microscopy
Immunolabeling fluorescence microscopy was used to determine the localization of PSCDBP, TLR2, and RGS12 on human primary uterine smooth muscle cells, passage number 5. PSCDBP localized to the cytoplasm of the cell, mainly surrounding the nucleus (Figure 4A to C). RGS12 appeared to localize to the cytoplasm of the uterine smooth muscle cells ( Figure 4D ). TLR2 protein was expressed in the cytoplasm and possibly also on the uterine smooth muscle cell membrane ( Figure 4E and F).
Immunogold Transmission Electron Microscopy
Electron micrographs of pregnant nonlaboring human uterine smooth muscle are indicated in Figure 5 , where RGS12 was immunologically detected in human myometrium isolated from pregnant nonlaboring myometrium by immunogold transmission electron microscopy, where it mostly appeared to localize close to or in vacuoles of the smooth muscle cell cytoplasm ( Figure 5A and B) .
DISCUSSION
This study compared gene expression levels in the human myometrium at term pregnancy and at labor. Although it has been previously established that there is differential spatial regulation in this tissue, we concentrated on expression changes in the lower uterine segment. 7, 15, 16 DIG-labeled mRNA isolated from the lower uterine segment of 3 NL and 3 L women was hybridized separately to more than 29 000 genes, represented by 60mer oligonucleotide probes. The resultant signal was detected with anti-DIG antibody alkaline phosphatase conjugate and slides were scanned with a chemiluminescent microarray analyzer incorporating a charge-coupled device (CCD) camera. Another microarray experiment by Havelock et al 6 compared gene expression in fundal laboring and nonlaboring human myometrium using 4 pooled samples of each, or with 1 sample from each group, with 9182 cDNA probes and fluorescence detection. Of the upregulated human myometrial fundal genes identified by this study, EGR1 and TNFRS11B were identified to be upregulated 10.1-fold (P = .048) and 9.8-fold (P = .004) respectively, in the lower uterine segment of the myometrium in our study. Esplin et al 5 also examined differential gene expression in lower uterine segment myometrium, laboring (n = 5) and nonlaboring (n = 5), using cloned 6912 cDNA microarrays and fluorescence detection, where 56 genes were determined to be differentially expressed at labor. Of the genes identified by this study, CCl2 was also identified to be regulated (12-fold, P = .038) in the lower uterine segment of the myometrium by our investigation. 14 Finally, Bukowski et al 7 investigated gene expression changes, without pooling, in the uterine fundus, lower segment, and cervix, all from the same patients, prior to the onset of labor (n = 6) or at labor (n = 7) using 25mer oligonucleotide microarrays of 12 626 genes probed with biotin labeled RNA and scanned with a confocal microscope. Among the human myometrium lower uterine segment genes identified by this investigation, some were also identified by our study (though not yet verified by RT-PCR), including HLF and TAGLN2, both of which were found to be upregulated, 2.1-fold (P = .002) and 1.4-fold (P = .02), respectively, at labor, whereas CAMKK2 was downregulated (1.4-fold, P = .01) at labor. 7 Although the above experiments use different microarray slides, detection systems, data analyses, patient numbers, and myometrial samples, there is some overlap in gene expression patterns. Our experiment, however, investigates expression of a larger number of genes with longer probe lengths than previous oligonucleotide microarray experiments, with DIG-labeled antibody and CCD camera detection. A number of genes from previously published northern or RT-PCR data including upregulated human IL6 and PLA2G2A and rat Junb gene expression at labor were also identified by our study. 12, 13, 17 In this study, we have shown for the first time the expression of PSCDBP, TLR2, TWIST1, FLJ35382, and RGS12 genes within the human myometrium and also upregulation of their expression and that of EDNRB in human myometrium at labor. PSCDBP is an intracellular scaffold protein that has been implicated in intercellular adhesion of lymphoid cells by regulating integrin deactivation and cytoskeletal rearrangements. 18, 19 Although Pscdbp mRNA has been shown to be upregulated by estrogen in mouse uterus, 20 no information regarding the expression or function of PSCDBP in the human reproductive system is currently available. PSCDBP transcription is upregulated by cytokines, including IL-2 and IL-12, in cultured lymphocytes, 18 and roles in leukocyte trafficking, especially in response to proinflammatory cytokines in stress conditions, and T cell receptor mediated signaling have also been proposed. 21, 22 Our data showed a 10fold upregulation of PSCDBP mRNA expression in the human myometrium at labor. PSCDBP expression was localized to myometrial smooth muscle cells for the first time. In myometrial smooth muscle cells, PSCDBP appears to localize in a vesicular manner within the cytoplasm and about the nuclear periphery. Although the exact function of PSCDBP in the myometrium remains to be elucidated, our findings suggest the possible involvement of PSCDBP in the signal transduction mechanisms associated with labor.
Spontaneous labor at term and preterm delivery with histological chorioamnionitis, regardless of membrane status, is associated with an increased mRNA expression of the tolllike receptor family members, TLR2 and TLR4, in the chorioamniotic membranes. 23 Murine models of inflammation-induced preterm birth have demonstrated an upregulation of Tlr2 in the uterus, and also, its activation has resulted in induction of preterm delivery. 24, 25 Furthermore,the expression of Tlr2 increased in the mouse uterus throughout normal gestation, to labor and postpartum. 26 Although TLR2 mRNA was previously reported in human uterus, 27 our findings have demonstrated a 7.59-fold upregulation of TLR2 expression in the human myometrium at labor.We have also displayed TLR2 expression in myometrial smooth muscle cells where the protein appeared to localize to the cytoplasm and possibly also to the cell membrane. As all the patients included in this study delivered at term and showed no evidence of chorioamnionitis, it is possible that TLR2 may play a role in the process of non-infection-related normal labor.
TWIST1 is a highly conserved transcription factor that belongs to the family of basic helix-loop-helix proteins and has been implicated in the differentiation of multiple cell lineages including muscle and cartilage. 28 Germ-line mutations in the coding sequence of the human TWIST1 gene have been identified in Saethre-Chotzen syndrome, and aberrant TWIST1 expression has also been observed in diverse types of cancers. 29, 30 TWIST expression is activated by TNF-α and IL-1β, via activation of NF-κB. TWIST1 binds to E-boxes in the promoters of several NF-kBdependent inflammatory cytokines, such as Tnfα and Il1β, and suppresses cytokine production by blocking NF-κBdependent transcriptional activation, thus completing a negative feedback loop. 31 TWIST1 also mediates suppression of inflammation by type I interferons, by repression of the Tnfα promoter. 32 TWIST1 also plays an important role in regulating smooth muscle cell differentiation and phenotypic modulation by binding to E-boxes in the promoter regions of several genes including smooth muscle alpha actin. 33 Significant upregulation of TWIST1 mRNA was demonstrated in human myometrium at term labor, whereas TWIST1 protein expression was observed in human myometrial smooth muscle cells. The role of TWIST1 in the human uterus remains to be fully elucidated; however, it may be involved in the control of inflammatory processes at labor either by suppression of cytokine signaling or regulation of known labor associated genes.
FLJ35382 is a hypothetical protein, which shows significant homology to splicing factor, SF3a60, part of the 17S U2 small nuclear ribonucleoprotein. In our study, we identified FLJ35382 as being differentially expressed in labor, generating an 11.3-fold change in the human myometrium at labor. Further investigations, however, are required to elucidate the role of this gene in the myometrium, whether it is involved in splicing or other pathways.
EDNRB is a G-protein coupled heptahelical endothelin-1 (EDN1) receptor. EDN1, a known mediator of human myometrial contraction in vitro, belongs to a family of three 21-amino acid isopeptides. The other EDN1 receptor, EDNRA, is selective for EDN1, 34 whereas EDNRB exhibits similar affinities for all 3 EDN isopeptides. 35 Although both endothelin receptors have been identified in the human myometrium, 36 it is thought that only the EDNRA receptor mediates the contractile effect of EDN1 both in vivo and in vitro. [37] [38] [39] EDNRB binding was decreased in rat placenta and uterus as a result of hypoxia, 40 and under inflammatory conditions, the major endothelin receptor subtype expressed in myometrial cells shifts from EDNRA to EDNRB, with a concomitant decrease in EDN1 release, leading to a loss of EDN1-induced myometrial cell contraction. 41 Interestingly, we found for the first time a significant upregulation of EDNRB during normal labor, which may suggest a role for EDNRB in noninfection, nonhypoxic associated human labor.
RGS12 is a member of the regulator of G-protein signaling (RGS) group of proteins that are involved in G-protein coupled receptor signaling and a wide variety of other functions, enabled by the variety of RGS protein structure and the ability to interact with other cellular molecules. RGS12 interacts with both N-type and Ca(v)2.2 Ca 2+ channels and also binds a C-terminal motif found in proteins such as the IL-8 receptor. [42] [43] [44] We observed a >5-fold change in RGS12 mRNA expression between nonlaboring and laboring myometrium. Western blotting demonstrated expression of RGS12 in human myometrial smooth muscle cells, and immunofluorescence microscopy localized it to the cell cytoplasm. Furthermore, immunogold labeling transmission electron microscopy of pregnant myometrium established that RGS12 was in close proximity to or in vacuoles of the smooth muscle cells. To our knowledge, this is the first study to identify RGS12 in the human myometrium and to demonstrate the upregulation of an RGS mRNA during labor. The diversity of the RGS protein structure clearly underlies a complex and broad range of physiological roles for this family, and particularly RGS12, in the myometrium during labor.
In conclusion, our data have identified the expression of several genes for the first time in the human myometrium and have demonstrated their and others' upregulation in the tissue during labor. Although little data exist pertaining to these genes in the human reproductive setting, nonetheless, their identification provides novel avenues for future study with the aim of elucidating the underlying molecular mechanisms driving human labor.
